Home » FORBES MEDI-TECH ANNOUNCES PHARMAVITE CONTRACT RENEWAL
FORBES MEDI-TECH ANNOUNCES PHARMAVITE CONTRACT RENEWAL
Forbes Medi-Tech Inc. today announced it has extended its supply and licensing
contract with Pharmavite LLC until mid 2007 for the continued sale of Reducol,
the branded cholesterol lowering ingredient in one of Pharmavite's leading dietary
supplements, Nature Made CholestOff. "The renewal of business between Pharmavite
and Forbes is the result of a successful strategic partnership and strong CholestOff
sales," said Laura Wessman, Senior Vice President, Operations at Forbes.
Business
Wire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May